ALX ONCOLOGY HOLDINGS INC financial data

Symbol
ALXO on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 09 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 339% % -34%
Debt-to-equity 60% % 85%
Return On Equity -182% % -94%
Return On Assets -114% % -60%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131,608,278 shares 146%
Common Stock, Shares, Outstanding 54,388,022 shares 2.5%
Entity Public Float $18,000,000 USD -93%
Common Stock, Value, Issued $54,000 USD 1.9%
Weighted Average Number of Shares Outstanding, Basic 53,658,399 shares 2.8%
Weighted Average Number of Shares Outstanding, Diluted 53,658,399 shares 2.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $76,996,000 USD -34%
General and Administrative Expense $23,850,000 USD -8.6%
Operating Income (Loss) $104,021,000 USD 27%
Net Income (Loss) Attributable to Parent $101,695,000 USD 25%
Earnings Per Share, Basic -1.9 USD/shares 26%
Earnings Per Share, Diluted -1.9 USD/shares 26%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $16,373,000 USD -6.8%
Other Assets, Current $20,000 USD -26%
Assets, Current $50,727,000 USD -62%
Property, Plant and Equipment, Net $1,200,000 USD -59%
Operating Lease, Right-of-Use Asset $1,159,000 USD -71%
Other Assets, Noncurrent $3,625,000 USD -48%
Assets $59,046,000 USD -60%
Accounts Payable, Current $4,914,000 USD 9.3%
Employee-related Liabilities, Current $4,356,000 USD -18%
Liabilities, Current $24,553,000 USD 33%
Operating Lease, Liability, Noncurrent $2,561,000 USD -26%
Other Liabilities, Noncurrent $3,980,000 USD -36%
Liabilities $33,065,000 USD -3.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $28,000 USD -90%
Retained Earnings (Accumulated Deficit) $722,817,000 USD -16%
Stockholders' Equity Attributable to Parent $25,981,000 USD -77%
Liabilities and Equity $59,046,000 USD -60%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $24,663,000 USD 35%
Net Cash Provided by (Used in) Financing Activities $65,000 USD -98%
Net Cash Provided by (Used in) Investing Activities $27,645,000 USD 4.4%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 54,388,022 shares 2.5%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16,439,000 USD -6.8%
Deferred Tax Assets, Valuation Allowance $149,682,000 USD 16%
Operating Lease, Liability $3,462,000 USD -22%
Payments to Acquire Property, Plant, and Equipment $60,000 USD -59%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $101,942,000 USD 24%
Lessee, Operating Lease, Liability, to be Paid $4,168,000 USD -24%
Property, Plant and Equipment, Gross $3,179,000 USD -36%
Operating Lease, Liability, Current $901,000 USD -5.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.095 pure 5.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $706,000 USD -34%
Deferred Tax Assets, Operating Loss Carryforwards $71,139,000 USD 73%
Unrecognized Tax Benefits $4,730,000 USD 15%
Operating Lease, Payments $322,000 USD 2.9%
Depreciation, Depletion and Amortization $211,000 USD -1.4%
Deferred Tax Assets, Net of Valuation Allowance $150,243,000 USD 15%
Share-based Payment Arrangement, Expense $12,579,000 USD -54%
Interest Expense $1,602,000 USD -7.3%